Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study

Hormone Research in Paediatrics

Volumn 76, Issue 6, 2011, Pages 386-391

  Geffner, Mitchell E ^a   Patel, Kunjal ^b,c   Miller, Tracie L ^d   Hazra, Rohan ^e   Silio, Margarita ^f   Van Dyke, Russell B ^f   Borkowsky, William ^g   Worrell, Carol ^e   Dimeglio, Linda A ^h   Jacobson, Denise L ^c  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^g NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^h INDIANA UNIVERSITY   (United States)

Author keywords

Highly active antiretroviral therapy; HIV; Homeostatic model assessment of insulin resistance; Insulin resistance

Indexed keywords

ABACAVIR; ALANINE AMINOTRANSFERASE; AMPRENAVIR; DIDANOSINE; HEMOGLOBIN A1C; INDINAVIR; LOPINAVIR; NELFINAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE;

ADOLESCENT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY GROWTH; BODY MASS; CHILD; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GLUCOSE TOLERANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PERINATAL INFECTION; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; BODY MASS INDEX; CARBAMATES; CD4 LYMPHOCYTE COUNT; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE INTOLERANCE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; PREVALENCE; PROSPECTIVE STUDIES; PUBERTY; SULFONAMIDES; UNITED STATES;

EID: 83855160811     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000332957     Document Type: Article

References (25)

1. Domingos H, Cunha RV, Paniago AM, Martins DM, Elkhoury EB, Souza AS: Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients. Braz J Infect Dis 2009; 13: 130-136.
2. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS: Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005; 165: 1179-1184. (Pubitemid 40720744)
3. Drechsler H, Powderly WG: Switching effective antiretroviral therapy: a review. Clin Infect Dis 2002; 35: 1219-1230. (Pubitemid 35305870)
4. Lee GA, Seneviratne T, Noor MA, Lo JC, Schwarz JM, Aweeka FT, Mulligan K, Schambelan M, Grunfeld C: The metabolic effects of lopinavir/ritonavir in HIV-negative men. AIDS 2004; 18: 641-649. (Pubitemid 38393463)
5. Lee B, Aurpibul L, Sirisanthana V, Mangklabruks A, Sirisanthana T, Puthanakit T: Low prevalence of insulin resistance among HIVinfected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand. HIV Med 2009; 10: 72-78.
6. Rosso R, Parodi A, d'Annunzio G, Ginocchio F, Nicolini L, Torrisi C, Sormani MP, Lorini R, Viscoli C, Vignolo M: Evaluation of insulin resistance in a cohort of HIV-infected youth. Eur J Endocrinol 2007; 157: 655-659. (Pubitemid 350187383)
7. Levy-Marchal C, Arslanian S, Cutfield W, Sinaiko A, Druet C, Marcovecchio ML, Chiarelli F; on behalf of ESPE-LWPESISPAD- APPES-APEG-SLEP-JSPE; and the Insulin Resistance in Children Consensus Conference Group: Insulin resistance in children: Consensus, perspective, and future directions. J Clin Endocrinol Metab 2010; 95: 5189-5198.
8. Hardy H, Esch LD, Morse GD: Glucose disorders associated with HIV and its drug therapy. Ann Pharmacother 2001; 35: 343-351. (Pubitemid 32201719)
9. Spagnuolo MI, Bruzzese E, Vallone GF, Fasano N, De Marco G, Officioso A, Valerio G, Volpicelli M, Iorio R, Franzese A, Guarino A: Is resistin a link between highly active antiretroviral therapy and fat redistribution in HIV-infected children? J Endocrinol Invest 2008; 31: 592-596.
10. Hruz PW: Molecular mechanisms for altered glucose homeostasis in HIV infection. Am J Infect Dis 2006; 2: 187-192.
11. Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Maurer KR, Johnson CL: Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 1998; 27: 879-890. (Pubitemid 29010857)
12. Valerio G, Licenziati MR, Iannuzzi A, Franzese A, Siani P, Riccardi G, Rubba P: Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis 2006; 16: 279-284. (Pubitemid 43983096)
13. Bitnun A, Sochett E, Dick PT, To T, Jefferies C, Babyn P, Forbes J, Read S, King SM: Insulin sensitivity and beta-cell function in protease inhibitor-treated and -naive human immunodeficiency virus-infected children. J Clin Endocrinol Metab 2005; 90: 168-174. (Pubitemid 40116652)
14. Aldrovandi GM, Lindsey JC, Jacobson DL, Zadzilka A, Sheeran E, Moye J, Borum P, Meyer WA 3rd, Hardin DS, Mulligan K; Pediatric AIDS Clinical Trials Group P1045 team: Morphologic and metabolic abnormalities in vertically HIV-infected children and youth. AIDS 2009; 23: 661-672.
15. Li C, Ford ES, Zhao G, Mokdad AH: Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006. Diabetes Care 2009; 32: 342-347.
16. Wei C, Ford A, Hunt L, Crowne EC, Shield JP: Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic. Arch Dis Child 2010, Epub ahead of print.
17. Jones KL: The dilemma of the metabolic syndrome in children and adolescents: disease or distraction? Pediatr Diabetes 2006; 7: 311-321. (Pubitemid 44921104)
18. Dubé MP, Qian D, Edmondson-Melançon H, Sattler FR, Goodwin D, Martinez C, Williams V, Johnson D, Buchanan TA: Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy. Clin Infect Dis 2002; 35: 475-481. (Pubitemid 34852578)
19. Bitnun A, Sochett E, Babyn P, Holowka S, Stephens D, Read S, King SM: Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitortreated and naive HIV-infected children. AIDS 2003; 17: 1319-1327. (Pubitemid 36819846)
20. Beregszaszi M, Dollfus C, Levine M, Faye A, Deghmoun S, Bellal N, Houang M, Chevenne D, Hankard R, Bresson JL, Blanche S, Levy-Marchal C: Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children. J Acquir Immune Defic Syndr 2005; 40: 161-168. (Pubitemid 41395714)
21. Ergun-Longmire B, Lin-Su K, Dunn AM, Chan L, Ham K, Sison C, Stavola J, Vogiatzi MG: Effects of protease inhibitors on glucose tolerance, lipid metabolism, and body composition in children and adolescents infected with human immunodeficiency virus. Endocr Pract 2006; 12: 514-521. (Pubitemid 46456038)
22. Viganò A, Brambilla P, Pattarino G, Stucchi S, Fasan S, Raimondi C, Cerini C, Giacomet V, Zuccotti GV, Bedogni G: Long-term evaluation of glucose homeostasis in a cohort of HAART-treated HIV-infected children: a longitudinal, observational cohort study. Clin Drug Investig 2009; 29: 101-109.
23. Johnsen S, Dolan SE, Fitch KV, Kanter JR, Hemphill LC, Connelly JM, Lees RS, Lee H, Grinspoon S: Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome. J Clin Endocrinol Metab 2006; 91: 4916-4924. (Pubitemid 44917327)
24. Kim PS, Woods C, Georgoff P, Crum D, Rosenberg A, Smith M, Hadigan C: A1C underestimates glycemia in HIV infection. Diabetes Care 2009; 32: 1591-1593.
25. Skelton JA, Cook SR, Auinger P, Klein JD, Barlow SE: Prevalence and trends of severe obesity among US children and adolescents. Acad Pediatr 2009; 9: 322-329.